206 related articles for article (PubMed ID: 20124094)
1. Quantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancer.
Tátrai P; Egedi K; Somorácz A; van Kuppevelt TH; Ten Dam G; Lyon M; Deakin JA; Kiss A; Schaff Z; Kovalszky I
J Histochem Cytochem; 2010 May; 58(5):429-41. PubMed ID: 20124094
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma.
Batmunkh E; Tátrai P; Szabó E; Lódi C; Holczbauer A; Páska C; Kupcsulik P; Kiss A; Schaff Z; Kovalszky I
Hum Pathol; 2007 Oct; 38(10):1508-15. PubMed ID: 17640714
[TBL] [Abstract][Full Text] [Related]
3. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of heparan sulfate 6-O-sulfotransferases in human embryonic kidney 293 cells results in increased N-acetylglucosaminyl 6-O-sulfation.
Do AT; Smeds E; Spillmann D; Kusche-Gullberg M
J Biol Chem; 2006 Mar; 281(9):5348-56. PubMed ID: 16326709
[TBL] [Abstract][Full Text] [Related]
5. Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders.
Zhu ZW; Friess H; Wang L; Abou-Shady M; Zimmermann A; Lander AD; Korc M; Kleeff J; Büchler MW
Gut; 2001 Apr; 48(4):558-64. PubMed ID: 11247902
[TBL] [Abstract][Full Text] [Related]
6. Acute UV irradiation increases heparan sulfate proteoglycan levels in human skin.
Jung JY; Oh JH; Kim YK; Shin MH; Lee D; Chung JH
J Korean Med Sci; 2012 Mar; 27(3):300-6. PubMed ID: 22379342
[TBL] [Abstract][Full Text] [Related]
7. Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer.
Fernández-Vega I; García O; Crespo A; Castañón S; Menéndez P; Astudillo A; Quirós LM
BMC Cancer; 2013 Jan; 13():24. PubMed ID: 23327652
[TBL] [Abstract][Full Text] [Related]
8. Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling.
Lamanna WC; Frese MA; Balleininger M; Dierks T
J Biol Chem; 2008 Oct; 283(41):27724-27735. PubMed ID: 18687675
[TBL] [Abstract][Full Text] [Related]
9. Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains.
Kato M; Wang H; Bernfield M; Gallagher JT; Turnbull JE
J Biol Chem; 1994 Jul; 269(29):18881-90. PubMed ID: 8034644
[TBL] [Abstract][Full Text] [Related]
10. Alterations in heparan sulfate in the vessel in response to vascular injury in the mouse.
Adhikari N; Rusch M; Mariash A; Li Q; Selleck SB; Hall JL
J Cardiovasc Transl Res; 2008 Sep; 1(3):236-40. PubMed ID: 19396363
[TBL] [Abstract][Full Text] [Related]
11. Heparanase-1-induced shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell facilitates lymphatic endothelial cell proliferation via VEGF-C/ERK pathway.
Yu S; Lv H; Zhang H; Jiang Y; Hong Y; Xia R; Zhang Q; Ju W; Jiang L; Ou G; Zhang J; Wang S; Zhang J
Biochem Biophys Res Commun; 2017 Apr; 485(2):432-439. PubMed ID: 28209511
[TBL] [Abstract][Full Text] [Related]
12. Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosis.
Westergren-Thorsson G; Hedström U; Nybom A; Tykesson E; Åhrman E; Hornfelt M; Maccarana M; van Kuppevelt TH; Dellgren G; Wildt M; Zhou XH; Eriksson L; Bjermer L; Hallgren O
Int J Biochem Cell Biol; 2017 Feb; 83():27-38. PubMed ID: 27974233
[TBL] [Abstract][Full Text] [Related]
13. Heparan sulfate chains with antimitogenic properties arise from mesangial cell-surface proteoglycans.
Wang A; Miralem T; Templeton DM
Metabolism; 1999 Oct; 48(10):1220-9. PubMed ID: 10535382
[TBL] [Abstract][Full Text] [Related]
14. Epigenetics: methylation-associated repression of heparan sulfate 3-O-sulfotransferase gene expression contributes to the invasive phenotype of H-EMC-SS chondrosarcoma cells.
Bui C; Ouzzine M; Talhaoui I; Sharp S; Prydz K; Coughtrie MW; Fournel-Gigleux S
FASEB J; 2010 Feb; 24(2):436-50. PubMed ID: 19812376
[TBL] [Abstract][Full Text] [Related]
15. Agrin, a novel basement membrane component in human and rat liver, accumulates in cirrhosis and hepatocellular carcinoma.
Tátrai P; Dudás J; Batmunkh E; Máthé M; Zalatnai A; Schaff Z; Ramadori G; Kovalszky I
Lab Invest; 2006 Nov; 86(11):1149-60. PubMed ID: 16983329
[TBL] [Abstract][Full Text] [Related]
16. Structural alteration of cell surface heparan sulfate through the stimulation of the signaling pathway for heparan sulfate 6-O-sulfotransferase-1 in mouse fibroblast cells.
Nishida M; Kozakai T; Nagami K; Kanamaru Y; Yabe T
Biosci Biotechnol Biochem; 2014; 78(5):770-9. PubMed ID: 25035978
[TBL] [Abstract][Full Text] [Related]
17. Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases.
Roskams T; Rosenbaum J; De Vos R; David G; Desmet V
Hepatology; 1996 Sep; 24(3):524-32. PubMed ID: 8781318
[TBL] [Abstract][Full Text] [Related]
18. Structural requirements of heparan sulfate for the binding to the tumor-derived adhesion factor/angiomodulin that induces cord-like structures to ECV-304 human carcinoma cells.
Kishibe J; Yamada S; Okada Y; Sato J; Ito A; Miyazaki K; Sugahara K
J Biol Chem; 2000 May; 275(20):15321-9. PubMed ID: 10809767
[TBL] [Abstract][Full Text] [Related]
19. Heparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional co-operativity.
Lamanna WC; Baldwin RJ; Padva M; Kalus I; Ten Dam G; van Kuppevelt TH; Gallagher JT; von Figura K; Dierks T; Merry CL
Biochem J; 2006 Nov; 400(1):63-73. PubMed ID: 16901266
[TBL] [Abstract][Full Text] [Related]
20. Differential sulfation remodelling of heparan sulfate by extracellular 6-O-sulfatases regulates fibroblast growth factor-induced boundary formation by glial cells: implications for glial cell transplantation.
Higginson JR; Thompson SM; Santos-Silva A; Guimond SE; Turnbull JE; Barnett SC
J Neurosci; 2012 Nov; 32(45):15902-12. PubMed ID: 23136428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
